Literature DB >> 28786131

Links between causal effects and causal association for surrogacy evaluation in a gaussian setting.

Anna Conlon1, Jeremy Taylor1, Yun Li1, Karla Diaz-Ordaz2, Michael Elliott1.   

Abstract

Two paradigms for the evaluation of surrogate markers in randomized clinical trials have been proposed: the causal effects paradigm and the causal association paradigm. Each of these paradigms rely on assumptions that must be made to proceed with estimation and to validate a candidate surrogate marker (S) for the true outcome of interest (T). We consider the setting in which S and T are Gaussian and are generated from structural models that include an unobserved confounder. Under the assumed structural models, we relate the quantities used to evaluate surrogacy within both the causal effects and causal association frameworks. We review some of the common assumptions made to aid in estimating these quantities and show that assumptions made within one framework can imply strong assumptions within the alternative framework. We demonstrate that there is a similarity, but not exact correspondence between the quantities used to evaluate surrogacy within each framework, and show that the conditions for identifiability of the surrogacy parameters are different from the conditions, which lead to a correspondence of these quantities.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  causal association; direct effects; principal stratification; surrogate markers; unmeasured confounders

Mesh:

Substances:

Year:  2017        PMID: 28786131      PMCID: PMC5675829          DOI: 10.1002/sim.7430

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  27 in total

1.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  Principal stratification and attribution prohibition: good ideas taken too far.

Authors:  Marshall Joffe
Journal:  Int J Biostat       Date:  2011-09-14       Impact factor: 0.968

3.  Bayesian inference for partially identified models.

Authors:  Paul Gustafson
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

4.  Identifiability and exchangeability for direct and indirect effects.

Authors:  J M Robins; S Greenland
Journal:  Epidemiology       Date:  1992-03       Impact factor: 4.822

5.  ASSESSING SURROGATE ENDPOINTS IN VACCINE TRIALS WITH CASE-COHORT SAMPLING AND THE COX MODEL.

Authors:  Li Qin; Peter B Gilbert; Dean Follmann; Dongfeng Li
Journal:  Ann Appl Stat       Date:  2008-03       Impact factor: 2.083

6.  Surrogacy assessment using principal stratification when surrogate and outcome measures are multivariate normal.

Authors:  Anna S C Conlon; Jeremy M G Taylor; Michael R Elliott
Journal:  Biostatistics       Date:  2013-11-26       Impact factor: 5.899

Review 7.  Principal stratification--a goal or a tool?

Authors:  Judea Pearl
Journal:  Int J Biostat       Date:  2011-03-30       Impact factor: 0.968

8.  Surrogate endpoints in clinical trials: definition and operational criteria.

Authors:  R L Prentice
Journal:  Stat Med       Date:  1989-04       Impact factor: 2.373

9.  A Bayesian approach to improved estimation of causal effect predictiveness for a principal surrogate endpoint.

Authors:  Corwin M Zigler; Thomas R Belin
Journal:  Biometrics       Date:  2012-02-20       Impact factor: 2.571

10.  A unification of mediation and interaction: a 4-way decomposition.

Authors:  Tyler J VanderWeele
Journal:  Epidemiology       Date:  2014-09       Impact factor: 4.822

View more
  1 in total

Review 1.  Informed decision-making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments.

Authors:  Christopher J Weir; Rod S Taylor
Journal:  Pharm Stat       Date:  2022-07       Impact factor: 1.234

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.